Abstract WP344: Total Healthcare Costs Before and After Stroke in Non-Valvular Atrial Fibrillation (NVAF) Patients Who Initiated Treatment With Rivaroxaban or Warfarin von Lin, Jennifer H, Milentijevic, Dejan, Shrivastava, Shubham, Kogan, Emily, Sjoeland, Erik, Alberts, Mark

Volltext

Abstract TP307: Validation of a Machine Learning Approach to Determine Stroke Severity of Patients Diagnosed With Stroke in Claims Data von Kogan, Emily, Sjoeland, Erik, Milentijevic, Dejan, Lin, Jennifer H, Alberts, Mark

Volltext

Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin von Milentijevic, Dejan, Lin, Jennifer H., Connolly, Nancy, Chen, Yen-Wen, Kogan, Emily, Shrivastava, Shubham, Sjoeland, Erik, Alberts, Mark J.

Volltext

Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin von Milentijevic, Dejan, Lin, Jennifer H., Chen, Yen-Wen, Kogan, Emily, Shrivastava, Shubham, Sjoeland, Erik, Alberts, Mark

Volltext